HomeSMMT • NASDAQ
Summit Therapeutics Inc
add
$19.10
1.11%
After Hours:(0.31%)-0.060
$19.04
Closed: Sep 22, 7:55:09 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 568.44M | 1,174.24% |
Net income | -565.71M | -836.84% |
Net profit margin | — | — |
Earnings per share | -0.57 | -703.84% |
EBITDA | -568.40M | -1,174.73% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 297.87M | -8.48% |
Total assets | 324.04M | -5.21% |
Total liabilities | 64.60M | -55.99% |
Total equity | 259.44M | — |
Shares outstanding | 742.85M | — |
Price to book | 53.97 | — |
Return on assets | -401.52% | — |
Return on capital | -461.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -565.71M | -836.84% |
Cash from operations | -66.74M | -102.24% |
Cash from investing | 150.81M | 175.37% |
Cash from financing | 2.22M | -98.89% |
Net change in cash | 86.35M | 362.80% |
Free cash flow | 147.49M | 11,930.09% |
Previous close
$18.89
Day range
$18.06 - $19.21
Year range
$15.55 - $36.91
Market cap
14.19B USD
Avg Volume
4.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
159
